ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,138, issued on Sept. 30, was assigned to SOUND PHARMACEUTICALS Inc. (Seattle).
"Treatment of Meniere's disease" was invented by Jonathan Kil (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel methods and compositions for treating MD and/or endolymphatic hydrops. The composition comprises ebselen and optionally one or more a glutathione peroxidase (GPx) modulator or mimic compounds and'or one or more prescription diuretic compounds. Also disclosed are methods of increasing GPx activity and reducing free radical species and cochlear or vestibular inflammation in a subject."
The patent was filed on May 18, 2017, under ...